Johns Hopkins University School of Medicine has granted Iverson Genetic Diagnostics an exclusive license to market a molecular diagnostic assay worldwide. The license covers an assay used to evaluate risks of infertility in women as well as cardiovascular disease in men and women. Terms of the deal were not made public.